Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
117.3 USD | -4.39% | -6.15% | +17.96% |
May. 10 | Equities Mostly Rise as Traders Parse Fed Officials' Comments, Consumer Sentiment Survey | MT |
May. 10 | S&P 500, Dow Rise as Traders Parse Fed Officials' Comments, Consumer Sentiment Survey | MT |
Financials (USD)
Sales 2024 * | 4.16B | Sales 2025 * | 4.83B | Capitalization | 44.96B |
---|---|---|---|---|---|
Net income 2024 * | -2.71B | Net income 2025 * | -1.96B | EV / Sales 2024 * | 9.31 x |
Net cash position 2024 * | 6.25B | Net cash position 2025 * | 3.94B | EV / Sales 2025 * | 8.49 x |
P/E ratio 2024 * |
-16.6
x | P/E ratio 2025 * |
-22.8
x | Employees | 5,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.4% |
Latest transcript on Moderna, Inc.
1 day | -4.39% | ||
1 week | -6.15% | ||
Current month | +6.35% | ||
1 month | +9.49% | ||
3 months | +34.21% | ||
6 months | +67.47% | ||
Current year | +17.96% |
Managers | Title | Age | Since |
---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 51 | 11-02-28 |
James Mock
DFI | Director of Finance/CFO | 47 | 22-09-05 |
Stephen Hoge
PSD | President | 48 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sagan
BRD | Director/Board Member | 65 | 18-05-31 |
Director/Board Member | 74 | 20-06-30 | |
Francois Nader
BRD | Director/Board Member | 67 | 19-12-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.66% | 0 M€ | 0.00% | - | |
4.69% | 2 M€ | -.--% | ||
4.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 117.3 | -4.39% | 4,238,508 |
24-05-09 | 122.7 | +0.66% | 3,367,379 |
24-05-08 | 121.9 | +0.68% | 2,507,503 |
24-05-07 | 121.1 | -0.87% | 2,894,011 |
24-05-06 | 122.1 | -2.30% | 3,953,207 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B | |
+20.18% | 11.72B |
- Stock Market
- Equities
- MRNA Stock